These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 25000478)
1. Increased A3AR-dependent vasoconstriction in diabetic mice is promoted by myeloperoxidase. Nishat S; Klinke A; Baldus S; Khan LA; Basir SF J Cardiovasc Pharmacol; 2014 Nov; 64(5):465-72. PubMed ID: 25000478 [TBL] [Abstract][Full Text] [Related]
2. An adenosine A3 receptor agonist inhibits DSS-induced colitis in mice through modulation of the NF-κB signaling pathway. Ren T; Tian T; Feng X; Ye S; Wang H; Wu W; Qiu Y; Yu C; He Y; Zeng J; Cen J; Zhou Y Sci Rep; 2015 Mar; 5():9047. PubMed ID: 25762375 [TBL] [Abstract][Full Text] [Related]
3. The infarct-sparing effect of IB-MECA against myocardial ischemia/reperfusion injury in mice is mediated by sequential activation of adenosine A3 and A 2A receptors. Tian Y; Marshall M; French BA; Linden J; Yang Z Basic Res Cardiol; 2015 Mar; 110(2):16. PubMed ID: 25711314 [TBL] [Abstract][Full Text] [Related]
4. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations. Mlejnek P; Dolezel P; Frydrych I J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730 [TBL] [Abstract][Full Text] [Related]
5. A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis. Lee HT; Kim M; Joo JD; Gallos G; Chen JF; Emala CW Am J Physiol Regul Integr Comp Physiol; 2006 Oct; 291(4):R959-69. PubMed ID: 16728466 [TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells. Mlejnek P; Dolezel P; Kosztyu P J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073 [TBL] [Abstract][Full Text] [Related]
7. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling. Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967 [TBL] [Abstract][Full Text] [Related]
8. Knockout of A3 adenosine receptors reduces mouse intraocular pressure. Avila MY; Stone RA; Civan MM Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3021-6. PubMed ID: 12202525 [TBL] [Abstract][Full Text] [Related]
10. Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression. Ochaion A; Bar-Yehuda S; Cohn S; Del Valle L; Perez-Liz G; Madi L; Barer F; Farbstein M; Fishman-Furman S; Reitblat T; Reitblat A; Amital H; Levi Y; Molad Y; Mader R; Tishler M; Langevitz P; Zabutti A; Fishman P Arthritis Res Ther; 2006; 8(6):R169. PubMed ID: 17101059 [TBL] [Abstract][Full Text] [Related]
11. Myeloperoxidase upregulates endothelin receptor type B expression. Lau D; Szöcs K; Klinke A; Rudolph T; Rudolph V; Streichert T; Blankenberg S; Baldus S J Mol Cell Cardiol; 2014 Apr; 69():76-82. PubMed ID: 24417960 [TBL] [Abstract][Full Text] [Related]
12. Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation. Morello S; Petrella A; Festa M; Popolo A; Monaco M; Vuttariello E; Chiappetta G; Parente L; Pinto A Cancer Biol Ther; 2008 Feb; 7(2):278-84. PubMed ID: 18059189 [TBL] [Abstract][Full Text] [Related]
13. Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells. Salvatore CA; Tilley SL; Latour AM; Fletcher DS; Koller BH; Jacobson MA J Biol Chem; 2000 Feb; 275(6):4429-34. PubMed ID: 10660615 [TBL] [Abstract][Full Text] [Related]
14. Attenuation of Sunitinib-induced cardiotoxicity through the A3 adenosine receptor activation. Sandhu H; Cooper S; Hussain A; Mee C; Maddock H Eur J Pharmacol; 2017 Nov; 814():95-105. PubMed ID: 28811127 [TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by A3 adenosine receptor agonist N-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism. Mlejnek P; Dolezel P Acta Physiol (Oxf); 2010 Jun; 199(2):171-9. PubMed ID: 20121715 [TBL] [Abstract][Full Text] [Related]
16. Species differences and mechanism of action of A Du L; Gao ZG; Paoletta S; Wan TC; Gizewski ET; Barbour S; van Veldhoven JPD; IJzerman AP; Jacobson KA; Auchampach JA Purinergic Signal; 2018 Mar; 14(1):59-71. PubMed ID: 29170977 [TBL] [Abstract][Full Text] [Related]
17. A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition. Madi L; Bar-Yehuda S; Barer F; Ardon E; Ochaion A; Fishman P J Biol Chem; 2003 Oct; 278(43):42121-30. PubMed ID: 12865431 [TBL] [Abstract][Full Text] [Related]
18. Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist. Fishman P; Bar-Yehuda S; Ardon E; Rath-Wolfson L; Barrer F; Ochaion A; Madi L Anticancer Res; 2003; 23(3A):2077-83. PubMed ID: 12894581 [TBL] [Abstract][Full Text] [Related]
19. Role of A3 adenosine receptor in diabetic neuropathy. Yan H; Zhang E; Feng C; Zhao X J Neurosci Res; 2016 Oct; 94(10):936-46. PubMed ID: 27319979 [TBL] [Abstract][Full Text] [Related]
20. Adenosine A(3) receptor-induced proliferation of primary human coronary smooth muscle cells involving the induction of early growth response genes. Hinze AV; Mayer P; Harst A; von Kügelgen I J Mol Cell Cardiol; 2012 Nov; 53(5):639-45. PubMed ID: 22906537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]